HCPLive Podcasts cover art

HCPLive Podcasts

Written by: HCPLive.com
Listen for free

  • Summary

  • Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows DocTalk, Rare Disease Report, Heart Team, Overdrive, and Derm Discussions. Music Courtesy of BenSound
    Show more Show less
Episodes
  • Andrew F. Alexis, MD, MPH: Discussing Controversies in Acne, Rosacea

    Andrew F. Alexis, MD, MPH: Discussing Controversies in Acne, Rosacea
    Mar 14 2024
    Episode Highlights:

    0:16 Intro

    0:28 Overview of presentation

    0:38 Acne and post-inflammatory hyperpigmentation

    01:35 Approaches to take

    03:21 Rosacea, use of dermoscopy and symptomatology assessment

    04:59 Necessity of inclusivity in clinical trials, other knowledge gaps

    06:05 Images used in education


    The American Academy of Dermatology (AAD) Annual Meeting in 2024 featured Dr. Andrew Alexis, a prominent figure in dermatology. Dr. Alexis, currently serving as the vice-chair for diversity in the department of dermatology and a professor of clinical dermatology at Weill Cornell Medical College in New York, presented a talk titled "Controversies in Acne and Rosacea."


    In the interview, he shed light on critical aspects of managing acne and rosacea, particularly focusing on patients with skin of color.


    Dr. Alexis advocated for inclusivity in clinical trials to improve understanding across diverse patient populations. He stressed the importance of expanding public awareness of rosacea in communities with skin of color and suggested incorporating diverse images into educational materials to better represent the spectrum of affected individuals.


    Dr. Alexis's insights underscore the necessity of tailored approaches and increased inclusivity in dermatological research and education to better serve patients with diverse skin tones and backgrounds.


    For additional information covered at the 2024 AAD conference, visit us at: https://www.hcplive.com/conference/aad.
    Show more Show less
    9 mins
  • New Insight: Role of Contract Research Organizations in Retina w/ Brad Doerschuk

    New Insight: Role of Contract Research Organizations in Retina w/ Brad Doerschuk
    Feb 29 2024
    In the medical community, a revolving cast of players plays a pivotal role in advancing scientific discovery and enhancing patient outcomes. During the research stage, a collaborative team effort, from the clinical trial sponsors to research sites and patient populations, is essential to ensure smooth progress and sustain momentum toward the finish line.

    The latest episode of New Insight with Veeral Sheth, MD features a conversation with Brad Doerschuk, the CEO of InFocus Clinical Research, on the important role of contract research organizations (CROs) in retina and the field of ophthalmology.

    In their conversation, Sheth and Doerschuk shed light on the role of CROs in managing clinical trials, dive into the evolution of the retina space in recent decades, and describe the challenges in recruiting for trials of new agents.

    Episode Highlights
    0:00 Introduction
    0:52 What is a CRO?
    2:13 Development of InFocus
    6:45 Discussing the retina pipeline
    11:46 Recruitment challenges, solutions
    15:50 Developing new clinical trial sites
    18:19 Relationship between investigators, CROs
    19:56 Shift in FDA guidance
    23:14 New trial endpoints
    25:16 Conclusion

    Every episode of New Insight is available on HCPLive.com and be sure to subscribe to our channel on Spotify and Apple Podcasts. Please direct any podcast-related inquiries to show producer Connor Iapoce at ciapoce@mjhlifesciences.com.
    Show more Show less
    30 mins
  • New Insight: Reengaging the Retina Community in 2024 w/ David Eichenbaum, MD and Roger Goldberg, MD

    New Insight: Reengaging the Retina Community in 2024 w/ David Eichenbaum, MD and Roger Goldberg, MD
    Feb 12 2024
    A special double-episode of New Insight with Veeral Sheth, MD features a well-rounded conversation on all things ophthalmology with returning guest David Eichenbaum, MD, the director of research for Retina Vitreous Associates of Florida, as well as first-time guest Roger Goldberg, MD, a vitreoretinal surgeon at Bay Area Retina Associates.

    The trio of retina specialists discuss recent conference news, the anniversary of a landmark agent, and what’s to come in 2024 for the specialty.

    Episode Highlights:
    0:00 Introduction
    1:25 Entering 2024
    7:34 The importance of treatment efficacy
    12:09 Re-engaging GA treatment
    15:05 Comparing aflibercept 8 mg and faricimab
    23:00 Real-world data sets
    26:30 What’s to come in 2024
    27:45 Intravitreal gene therapies
    31:00 Port delivery system
    36:00 Wrapping-up 

    Every episode of New Insight is available on HCPLive.com and be sure to subscribe to our channel on Spotify and Apple Podcasts. Please direct any podcast-related inquiries to show producer Connor Iapoce at ciapoce@mjhlifesciences.com.
    Show more Show less
    40 mins

What listeners say about HCPLive Podcasts

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.ca reviews

Amazon Reviews
No reviews are available